🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, multi-center, phase 1 study of BBI608 and BBI503 adm...
Status
Completed
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2015-04
Trial ID
NCT02432326
This was an open-label, single-arm, Phase II study in which amcasertib (BBI...
Status
Terminated
Location
Mayo Clinic
Start Date
2015-06
Trial ID
NCT02432690
Treatments Being Tested
This is an open label, multi-center, phase II study of BBI503 administered ...
Status
Completed
Location
University of Calgary
Start Date
2015-02
Trial ID
NCT02232633
Treatments Being Tested
This is an open label, multi-center, phase II study of BBI503 administered ...
Status
Terminated
Location
Princess Margaret Cancer Centre
Start Date
2017-03-13
Trial ID
NCT02232620
Treatments Being Tested
This is an open label, single arm dose escalation study of BBI503 in adult ...
Status
Completed
Location
Mayo Clinic Cancer Center, Scottsdale
Start Date
2012-02
Trial ID
NCT01781455
Treatments Being Tested
This is an open label, three-arm, phase 1 dose escalation study and phase 2...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2014-12
Trial ID
NCT02279719
This is an open-label, multicenter, phase 1 dose escalation study of BBI503...
Status
Completed
Location
5 Sites
Start Date
2015-03
Trial ID
NCT02354898
This is an open label, multi-center, Phase 1/2 study of BBI503 administered...
Status
Completed
Location
Parkview Research Center
Start Date
2015-09
Trial ID
NCT02483247
Treatments Being Tested
This is an open label, multi-center, Phase II study of BBI503 administered ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-01
Trial ID
NCT02232646
Treatments Being Tested